OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies
Shuailei Chang, Hongbo Liu, Jian Wu, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 469-469
Open Access | Times Cited: 12

Showing 12 citing articles:

Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 75

Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada
Kyla L. Naylor, S. Joseph Kim, Graham Smith, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 9, pp. 2228-2236
Open Access | Times Cited: 39

Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Zejun Li, Shouhuan Liu, Fengming Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
Frances Priddy, Spyros Chalkias, Brandon Essink, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 862-878
Open Access | Times Cited: 4

Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
Sascha Hein, Ines Mhedhbi, Tobias Zahn, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 796-796
Open Access | Times Cited: 15

Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis
Kaixin Guo, Peng Ni, Shuailei Chang, et al.
American Journal of Infection Control (2023) Vol. 51, Iss. 9, pp. 1049-1055
Closed Access | Times Cited: 7

Effectiveness of EV-A71 Vaccine and Its Impact on the Incidence of Hand, Foot and Mouth Disease: A Systematic Review
Quanman Hu, Yaqi Xie, Fucang Ji, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1028-1028
Open Access | Times Cited: 1

Cross-Sectional Survey on BNT162b2 mRNA COVID-19 Vaccine Serious Adverse Events in Children 5 to 11 Years of Age: A Monocentric Experience
Silvia Bloise, Alessia Marcellino, Beatrice Frasacco, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1224-1224
Open Access | Times Cited: 6

From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies
Lifeng Xu, Chao Li, Rui Liao, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 81-102
Closed Access

Page 1

Scroll to top